Results show that various classes of antidepressants exert improving effects on cognitive function across several cognitive domains .
Specifically , studies suggest that SSRIs , the SSRE tianeptine , the SNRI duloxetine , vortioxetine and other antidepressants such as bupropion and moclobemide may exert certain improving effects on cognitive function in depression , such as in learning and memory and executive function .
The few non-pharmacological studies conducted employing cognitive orientated treatments and cognitive remediation therapy show promising results for the improvement of cognitive impairment in depression .
Cognitive dysfunction is of clinical significance and exerts longst and ing implication on patients ׳ function .
Pharmacological and non-pharmacological treatments of cognitive dysfunction are emerging .
This review evaluates pharmacological and non-pharmacological treatments of cognitive impairment primarily in the domains of memory , attention , processing speed and executive function in clinical depression .
A randomized single-blind pilot study of compensatory strategies in schizophrenia outpatients.
In a previous study , we found that cognitive adaptation training (CAT)--a manual-driven program of environmental supports design ed to bypass cognitive deficits -- improved multiple domains of outcome in schizophrenia patients recently discharged from a State psychiatric facility . The present study examined the efficacy of CAT in a sample of patients who had been in the community at least 3 months . Forty-five medicated schizophrenia patients were r and omly assigned for 9 months to one of three conditions : ( 1 ) CAT , ( 2 ) a condition that controlled for therapist time and provided environmental changes unrelated to cognitive deficits , or ( 3 ) follow-up only . Comprehensive assessment s were conducted every 3 months by blinded raters . Results of repeated measures analyses of covariance for mixed models indicated that patients participating in CAT had better adaptive function and quality of life , and fewer positive symptoms than those in the two non-CAT conditions . Results indicate that compensatory strategies may improve various outcomes in schizophrenia out patients
Results show that various classes of antidepressants exert improving effects on cognitive function across several cognitive domains .
Specifically , studies suggest that SSRIs , the SSRE tianeptine , the SNRI duloxetine , vortioxetine and other antidepressants such as bupropion and moclobemide may exert certain improving effects on cognitive function in depression , such as in learning and memory and executive function .
The few non-pharmacological studies conducted employing cognitive orientated treatments and cognitive remediation therapy show promising results for the improvement of cognitive impairment in depression .
Cognitive dysfunction is of clinical significance and exerts longst and ing implication on patients ׳ function .
Pharmacological and non-pharmacological treatments of cognitive dysfunction are emerging .
This review evaluates pharmacological and non-pharmacological treatments of cognitive impairment primarily in the domains of memory , attention , processing speed and executive function in clinical depression .